Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene

J Mol Med (Berl). 1997 Apr;75(4):297-9. doi: 10.1007/s001090050115.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Multicenter Study

MeSH terms

  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Clinical Protocols
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Interleukin-2 / genetics*
  • Melanoma / genetics
  • Melanoma / therapy*

Substances

  • Cancer Vaccines
  • Interleukin-2